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Introduction {#sec1}
============

Obesity is characterized by an excessive accumulation of body fat from expansion of white adipose tissue (WAT). This remodeling process involves hypertrophy of pre-existing adipocytes and differentiation of committed precursor cells into adipocytes through adipogenesis. Adipocyte hypertrophy favors recruitment of inflammatory macrophages, adipose tissue dysfunction, and insulin resistance, whereas hyperplasia preserves WAT function and insulin sensitivity ([@bib36]). However, mechanisms behind WAT expansion through hypertrophy and/or adipogenesis are still poorly understood and pharmacological approaches available to prevent the development of obesity are very few. In this context, identifying molecular targets regulating WAT expansion is promising for the design of more efficient strategies to treat obesity and its associated complications.

Adipogenesis is a complex process resulting from the coordinated temporal and spatial expression of specific transcriptional regulators ([@bib24]). In this perspective, CCAAT enhancer binding proteins (C/EBPs) serve as master initiators of the preadipocyte differentiation process ([@bib37]). C/EBPβ and C/EBPδ are expressed early following the induction of adipogenesis. As a result, C/EBPα and peroxisome proliferator-activated receptor (PPAR) γ are induced and function together to promote the transcription of a large group of genes that govern the adipocyte phenotype and function ([@bib34], [@bib37]).

Our group has been at the forefront in unraveling the role of the Src homology (SH) domain-containing adaptor protein Nck2 (non-catalytic region of receptor tyrosine kinase 2) as a key player in limiting adipogenesis and adiposity, and regulating adipocyte function in mice ([@bib12], [@bib15]). In agreement, we found that Nck2 downregulation in human visceral WAT correlates with severe obesity ([@bib12]). At the mechanistic level, we demonstrated that Nck2 controls WAT homeostasis through the regulation of the endoplasmic reticulum (ER) transmembrane protein kinase R-like endoplasmic reticulum kinase (PERK), which plays a central role in the unfolded protein response (UPR) and critically contributes to lipogenesis and adipocyte differentiation ([@bib16]).

In mammals, Nck2 shares a high degree of identity with Nck1, a second member of the Nck family. Indeed, both lack catalytic activity and contain three SH3 and one SH2 domains that are particularly well conserved ([@bib6]). These adaptor proteins facilitate the assembly of molecular complexes coupling cell surface and ER transmembrane receptor signaling to crucial cellular responses, such as proliferation, actin cytoskeleton reorganization, and ER stress-induced UPR (reviewed in [@bib20]). We previously reported that Nck1 is required to sustain ER stress-induced hepatic insulin resistance associated with impaired glucose homeostasis secondary to obesity ([@bib21]). However, a role for Nck1 in adipose tissue biology remains to be assessed.

Herein, using a combination of murine and human preadipocyte cell lines, as well as *in vivo* models, we demonstrate that, in contrast to Nck2 ([@bib12]), Nck1 is required for *in vivo* WAT development as well as *in vitro* differentiation of preadipocytes into adipocytes. We determined that the level of Nck1 mRNA correlates positively with the mRNA levels of adipogenic markers PPARγ and adiponectin in adipose tissues of obese humans. From a mechanistic perspective, we demonstrate that Nck1 deficiency inhibits adipogenesis through remodeling of preadipocytes mediated by enhanced PDGFRα activation and signaling.

Results {#sec2}
=======

Expression of Nck1 Increases during Developmental and Obesogenic WAT Expansion {#sec2.1}
------------------------------------------------------------------------------

We previously reported that Nck1 is widely expressed in mouse tissues ([@bib12]). However, further investigation of Nck1 expression in specific mouse adipose tissues reveals that epididymal (e) and subcutaneous (sc) WATs express similar levels, whereas a lower level of Nck1 is observed in brown adipose tissue (BAT) ([Figure 1](#fig1){ref-type="fig"}A). Furthermore, we found that Nck1 expression increases in eWAT and scWAT during aging ([Figure 1](#fig1){ref-type="fig"}B). To determine the cell type that contributes to an increase in Nck1 expression in WAT during development, we isolated adipocytes and adipocyte precursor cells (Lin−;CD29+;CD34+;Sca1+;PDGFRα+) following WAT collagenase digestion and fluorescence-activated cell sorting (FACS, [Figure S1](#mmc1){ref-type="supplementary-material"}A) as previously described ([@bib8]). As expected, in both eWAT and scWAT, adipocytes show higher levels of *Pparg* compared with adipocyte precursor cells ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Similarly, *Nck1* level appears higher in adipocytes than in preadipocytes, especially in older mice ([Figure 1](#fig1){ref-type="fig"}C). Interestingly, increased Nck1 at the protein level in eWAT and scWAT at week 16 post-weaning ([Figure 1](#fig1){ref-type="fig"}B) correlates at the same age with upregulation of Nck1 mRNA in adipocytes rather than in adipocyte precursor cells ([Figure 1](#fig1){ref-type="fig"}C). These results strongly suggest that during developmental WAT expansion, Nck1 expression mostly increases in adipocytes. Furthermore, Nck1 expression in eWAT from diet- and genetically induced obese mice (high-fat diet \[HFD\] and *ob/ob*) is also significantly increased ([Figure 1](#fig1){ref-type="fig"}D). Therefore, expression of Nck1 in WAT increases not only during normal development but also during WAT expansion associated with obesity. In agreement, we found that Nck1 mRNA positively correlates with PPARG and ADIPOQ mRNAs in omental (o) and subcutaneous (sc) WAT of obese humans ([Figure 1](#fig1){ref-type="fig"}E), further supporting the notion that increased expression of Nck1 relates to WAT expansion.Figure 1Nck1 Is Induced during Developmental and Obesogenic WAT Expansion(A) Relative expression of Nck1 in epididymal (e) and subcutaneous (sc) white adipose tissues (WAT) and brown adipose tissue (BAT) in mice as determined by western blot and densitometry of Nck1 relative to Hsp90 (n = 3/group).(B) Relative expression of Nck1 in eWAT and scWAT during development (post-weaning week 0, 5, and 16) as determined by western blot and densitometry relative to β-actin (n = 3/group).(C) Relative Nck1 mRNA levels in adipocytes and adipocyte precursors cells (Lin−;CD29+; CD34+;Sca1+;PDGFRα+) isolated from mice at weeks 5 and 16 post-weaning (n = 3--4/condition).(D) Nck1 protein level in eWAT of mice fed a normal chow diet (NCD) (n = 6) or a high-fat diet (HFD) (n = 4) and Nck1 mRNA level in *ob/ob* mice eWAT (n = 4). Data are mean ± SEM. Statistical significance evaluated by unpaired Student\'s t test or one-way ANOVA is reported as \*p ≤ 0.05, \*\*\*p ≤ 0.001.(E) Correlation of Nck1 mRNA with PPARγ and adiponectin mRNA level in omental (o) and subcutaneous (sc) WAT of obese humans (n = 12). Statistical significance evaluated by two-tailed p value from analysis of Pearson correlation coefficient as reported in the figure.

Nck1 Is Required for WAT Development {#sec2.2}
------------------------------------

To assess whether Nck1 contributes to postnatal WAT development *in vivo*, we characterized *Nck1*^+/+^ and *Nck1*^−/−^ mice from 0 to 16 weeks after weaning. As we previously reported ([@bib21]), *Nck1*^*−/−*^ mice display lower body weight early after weaning, but recover later on as shown by comparable body weight at week 16 (*Nck1*^*+/+*^: 38.83 g ± 1.26, *Nck1*^*−/−*^: 35.73 g ± 1.88; n = 9) ([Figure 2](#fig2){ref-type="fig"}A, inset). Under this time frame, eWAT and scWAT depots in *Nck1*^*−/−*^ mice tend to be smaller, and this difference becomes significant at 16 weeks after weaning ([Figure 2](#fig2){ref-type="fig"}B), whereas BAT weight remains unchanged ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Taking body weight into account, eWAT and scWAT depots are still significantly reduced in *Nck1*^*−/−*^ mice; excluding that smaller WAT depots at week 16 after weaning are due to lower overall body weight ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). Interestingly, other organ weights normalized to body weight are not different between mice genotypes ([Figure S2](#mmc1){ref-type="supplementary-material"}D), further highlighting a specific role for Nck1 in regulating WAT development *in vivo*.Figure 2Impaired WAT Development in *Nck1*^*−/−*^ Mice(A) Body weight between 0 and 5 weeks and at 16 weeks (inset) after weaning (n = 6--15/group).(B) Weight of eWAT and scWAT at 0, 5, and 16 weeks post-weaning (n = 5--16/group).(C) H&E staining showing representative images at 10× magnification of indicated WAT and adipocyte area distribution with diameter measurements of 1000--5000 cells in *Nck1*^*+/+*^ and *Nck1*^*−/−*^ mice at week 16 post-weaning (n = 3--4/group).(D) FACS quantification of adipocyte precursor cells (Lin−;CD29+; CD34+;Sca1+;PDGFRα+) count relative to Lin− cells population or per gram of fat in indicated WAT depots from *Nck1*^*+/+*^ and *Nck1*^*−/−*^ mice at week 5 post-weaning (n = 4/group).(E and F) (E) Oil red O staining and quantification and (F) PPARγ and aP2 levels as determined by western blot and densitometry relative to Hsp90 at day 5 of differentiation in scWAT SVF isolated from *Nck1*^*+/+*^ and *Nck1*^*−/−*^ mice at week 5 post-weaning (n = 3/group). Arrow represents PPARγ2 and \* is a non-specific band in Nck1 western blot. Data are mean ± SEM.Statistical significance evaluated by unpaired Student\'s t test or two-way ANOVA is defined as \*p ≤ 0.05, \*\*p ≤ 0.01, and \*\*\*\*p ≤ 0.0001.

*Nck1*^+/+^ and *Nck1*^−/−^ mice display similar insulin and leptin serum levels, as well as fed blood triglycerides and glucose levels ([Figure S2](#mmc1){ref-type="supplementary-material"}E). In addition, both mice genotypes were comparable in terms of metabolic and physical activities as shown by similar food and water intakes, energy expenditure, locomotor activity, O~2~ consumption and CO~2~ release, as well as respiratory exchange ratio ([Figure S3](#mmc1){ref-type="supplementary-material"}). Therefore, decreased adiposity in *Nck1*^*−/−*^ mice is not associated with obvious changes in metabolic or physical activity.

To further characterize decreased adiposity in *Nck1*^*−/−*^ mice, eWAT and scWAT sections from each mouse genotype were subjected to H&E staining and adipocyte area frequency distribution was quantified ([@bib33]). These analyses reveal no change in the size of adipocytes in eWAT between mice genotypes ([Figure 2](#fig2){ref-type="fig"}C, left panels). In contrast, it is clear that adipocytes are smaller and that the population of smaller adipocytes significantly increases in scWAT from *Nck1*^*−/−*^ mice ([Figure 2](#fig2){ref-type="fig"}C, right panels). We then further investigated the relationship between average adipocyte volume and respective weight for each WAT depot ([Figure S2](#mmc1){ref-type="supplementary-material"}F). For eWAT, this relationship is shifted to the left in *Nck1*^*−/−*^ mice, suggesting that a decreased number of adipocytes could contribute to smaller eWAT. For scWAT, the relationship between adipocyte volume and tissue weight is shifted to the left and downward in *Nck1*^*−/−*^ mice, suggesting that the smaller scWAT in these mice results from the lower number of adipocytes and decreased adipocyte size. To determine whether the decreased number of adipocytes in *Nck1*^*−/−*^ mice WAT depots is related to a reduced number of adipocyte precursor cells, we compared the number of Lin−;CD29+;CD34+; Sca1+; PDGFRα+ adipocyte precursor cells in both WAT depots between mice genotypes using FACS analysis as reported above ([Figure S1](#mmc1){ref-type="supplementary-material"}A). In agreement with the reduced number of adipocytes in eWAT and scWAT of *Nck1*^*−/−*^ mice, the number of adipocyte precursor cells is significantly decreased in both WAT depots when compared with *Nck1*^*+/+*^ mice ([Figure 2](#fig2){ref-type="fig"}D). The decreased number of adipocyte precursor cells persists even after considering the weight of each WAT ([Figure 2](#fig2){ref-type="fig"}D), as well as the absolute count of precursors ([Figure S2](#mmc1){ref-type="supplementary-material"}G). In addition, cells of stromal vascular fraction (SVF) isolated from *Nck1*^−/−^ mice scWAT display impaired adipogenesis as shown by reduced oil red O staining at day 5 of differentiation compared with *Nck1*^*+/+*^ scWAT SVF cells similarly treated ([Figure 2](#fig2){ref-type="fig"}E). In agreement, western blot analysis of day 5 differentiated scWAT SVF shows significantly reduced levels of PPARγ and its downstream target aP2 in *Nck1*^−/−^ mice compared with *Nck1*^+/+^ mice ([Figure 2](#fig2){ref-type="fig"}F). Therefore, impaired adipogenesis of SVF precursors isolated from scWAT of *Nck1*^−/−^ mice could be attributed to a reduced number of adipocyte precursor cells. However, this approach does not exclude an intrinsic adipogenesis defect in *Nck1*^−/−^ adipocyte precursor cells. Nonetheless, our findings demonstrate that Nck1 is required to maintain an adequate number of adipocyte precursor cells and WAT development.

Nck1 Is a Regulator of Adipogenesis {#sec2.3}
-----------------------------------

We observed that the expression of Nck1 at both mRNA and protein levels significantly increases during 3T3-L1 cells\' differentiation ([Figure 3](#fig3){ref-type="fig"}A), a well-established model of *in vitro* differentiation of preadipocyte into adipocyte ([@bib14]). To determine whether Nck1 regulates adipocyte differentiation in a cell-autonomous manner, we silenced Nck1 using specific small interfering RNA (siRNA) in 3T3-L1 preadipocytes. Indeed, we found that silencing Nck1 in 3T3-L1 preadipocytes strongly abrogates differentiation compared with cells transfected with control siRNA, as shown by the reduced accumulation of lipid droplets under light microscopy and quantification of oil red O staining ([Figure 3](#fig3){ref-type="fig"}B). In agreement, *Pparg* and *Fabp4* (aP2) levels are significantly reduced during differentiation in Nck1-depleted 3T3-L1 cells ([Figure 3](#fig3){ref-type="fig"}C). Western blot analysis at day 6 of differentiation demonstrates that siRNA-mediated Nck1 silencing is efficient given that Nck1 protein levels remain low in differentiated cells ([Figure 3](#fig3){ref-type="fig"}D). In addition, silencing Nck1 significantly reduces the expression of the main adipogenic markers PPARγ2, aP2, C/EBPα, perilipin, and adiponectin at day 6 of differentiation ([Figure 3](#fig3){ref-type="fig"}D). Therefore, these results demonstrate that Nck1 is important to induce the differentiation of murine 3T3-L1 preadipocytes into adipocytes.Figure 3Nck1 Is Required for 3T3-L1 Preadipocyte Differentiation(A) Nck1 mRNA (n = 4) and protein (n = 3) levels during 3T3-L1 preadipocyte differentiation.(B) Representative microscopic images (DIC, 10×) at days 0, 6, and 20 of differentiation and oil red O quantification in day 6 differentiated siControl and siNck1 3T3-L1 cells (n = 3/group).(C) Relative *Pparg* and *Fabp4* mRNA at indicated day of differentiation (n = 3/group).(D) Expression of adipogenic markers at day 6 of differentiation as determined by western blot and densitometry relative to Hsp90 (representative of n = 3). Arrow represents PPARγ2. Data are mean ± SEM.Statistical significance evaluated by one sample or unpaired Student\'s t test or two-way ANOVA is reported as \*p ≤ 0.05, \*\*p ≤ 0.01, and \*\*\*p ≤ 0.001.

Similarly to murine 3T3-L1 preadipocytes, Nck1 expression increases during *in vitro* differentiation of human Simpson-Golabi-Behmel Syndrome (SGBS) preadipocytes into adipocytes ([Figure S4](#mmc1){ref-type="supplementary-material"}A). In addition, silencing Nck1 in SGBS preadipocytes drastically reduces differentiation, as seen by both the lack of lipid droplet formation (light microscopy) and reduced lipid accumulation, revealed by decreased uptake of the lipophilic fluorescence dye, BODIPY, at day 12 of differentiation ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Consistently, the adipogenic markers PPARγ2, aP2, C/EBPα, perilipin, and adiponectin are significantly decreased in Nck1-deficient SGBS cells compared with control cells ([Figure S4](#mmc1){ref-type="supplementary-material"}C). All these changes cannot be attributed to the recovery of Nck1 expression or compensation by Nck2 throughout the induction of differentiation in Nck1-depleted SGBS cells, as Nck1 expression remains low and Nck2 expression does not change upon silencing Nck1 in SGBS cells ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Therefore, Nck1 expression increases during *in vitro* adipocyte differentiation, and loss of function of Nck1 in preadipocytes strongly impairs mouse and human preadipocyte differentiation into adipocytes.

To determine whether gain of function of Nck1 affects adipogenesis, pools of 3T3-L1 preadipocytes stably transfected with a plasmid driving ectopic expression of mouse Nck1 tagged with a FLAG epitope (FLAG-Nck1) or an empty plasmid were generated ([Figure 4](#fig4){ref-type="fig"}A). Following induction of differentiation, we observed that 3T3-L1 preadipocytes overexpressing FLAG-Nck1 display increased formation of lipid droplets (light microscopy) and expression of the adipogenic markers *Pparg* and *Fabp4* ([Figures 4](#fig4){ref-type="fig"}B and 4C). In addition, western blot analysis at day 6 of differentiation demonstrates that the expression of the main adipogenic markers PPARγ2, aP2, C/EBPα, perilipin, and adiponectin is increased in 3T3-L1 cells overexpressing FLAG-Nck1 when compared with control cells ([Figure 4](#fig4){ref-type="fig"}D). Overall, these results show that Nck1 loss and gain of function modulates *in vitro* adipocyte differentiation in a cell-autonomous manner.Figure 4Overexpression of Nck1 Promotes Differentiation of 3T3-L1 Preadipocytes into Adipocytes(A) Nck1 mRNA and protein levels in 3T3-L1 preadipocytes stably overexpressing murine FLAG-tagged Nck1.(B) Representative microscopic images (DIC, 10×) of 3T3-L1 control and FLAG-Nck1 cells at days 0 and 6 of differentiation (n = 3/group).(C) Relative expression of *Pparg* and *Fabp4* in 3T3-L1 control and FLAG-Nck1 cells at day 6 of differentiation (n = 3/group).(D) Western blots and quantification of adipogenic proteins in 3T3-L1 control and FLAG-Nck1 cells at day 6 of differentiation (representative of n = 3). Arrow represents PPARγ2. Data are mean ± SEM.Statistical significance evaluated by one sample or unpaired Student\'s t test is reported as \*p ≤ 0.05 and \*\*p ≤ 0.01.

Nck1 Deficiency Remodels Preadipocyte Signature {#sec2.4}
-----------------------------------------------

To explain how silencing Nck1 in preadipocytes impairs *in vitro* differentiation into adipocytes, we hypothesize that Nck1 is required to maintain preadipocyte commitment. Indeed, we found that silencing Nck1 affects preadipocyte function, as shown by reduced oleate-induced lipid uptake monitored by BODIPY FL C16 ([Figure 5](#fig5){ref-type="fig"}A). Accordingly, this correlates with lower mRNA and protein levels of the lipid transporter CD36 in Nck1-deficient 3T3-L1 preadipocytes ([Figure 5](#fig5){ref-type="fig"}B). On the other hand, silencing Nck1 in 3T3-L1 preadipocytes significantly enhances proliferation as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and bromodeoxyuridine (BrdU) incorporation ([Figure 5](#fig5){ref-type="fig"}C). Therefore, these results suggest that Nck1 regulates preadipocyte function. However, propidium iodide (PI) staining to monitor cell cycle progression in 2-day post-confluent preadipocytes and through the first phase of mitotic clonal expansion (MCE) induced by the differentiation cocktail (DMI) is comparable between Nck1-deficient and control 3T3-L1 preadipocytes ([Figure S5](#mmc1){ref-type="supplementary-material"}A). These data rule out that increased proliferation in Nck1-deficient preadipocytes impairs differentiation by altering MCE. Finally, Nck1-deficient preadipocytes show normal DMI-induced signaling, as demonstrated by comparable DMI-induced pAKT and pERK1/2 with control cells ([Figure S5](#mmc1){ref-type="supplementary-material"}B) Altogether, these results suggest that Nck1 deficiency more importantly affects preadipocyte fate than events related to the induction of differentiation into adipocyte.Figure 5Silencing Nck1 Remodels 3T3-L1 Preadipocyte Signature(A) BODIPY FL C16 uptake during 48 hr with DAPI-stained siControl and siNck1 3T3-L1 preadipocytes (n = 3/group).(B) Relative expression of CD36 mRNA and protein in siControl and siNck1 3T3-L1 preadipocytes (representative of n = 3).(C) Preadipocyte proliferation assessed using MTT assay and quantification of BrdU-positive cells (n = 3/group).(D) Relative mRNA expression of adipogenic master genes in growing and at day 0 of differentiation (n = 3/group).(E) PPARγ expression at day 0 of differentiation as determined by western blots. Arrow indicates PPARγ2 (representative of n = 3). Data are mean ± SEM.Statistical significance evaluated by unpaired Student\'s t test or two-way ANOVA is reported as \*p ≤ 0.05, \*\*\*p ≤ 0.001, and \*\*\*\*p ≤ 0.0001.

To get more insight into the potential mechanism underlying Nck1-dependent regulation of preadipocyte function, we compared the expression levels of adipogenic markers in control and Nck1-deficient 3T3-L1 preadipocytes. Interestingly, growing Nck1-deficient preadipocytes only show a significant slight decrease in *Pparg*, whereas the level of *Cebps* is significantly unchanged ([Figure 5](#fig5){ref-type="fig"}D). In contrast, *Pparg* and *Cebps* levels are significantly reduced at day 0 of differentiation when preadipocytes are growth arrested ([Figure 5](#fig5){ref-type="fig"}D). In agreement, PPARγ protein levels are significantly reduced upon silencing Nck1 in 3T3-L1 preadipocytes ([Figure 5](#fig5){ref-type="fig"}E). These results suggest that impaired adipocyte differentiation of Nck1-depleted cells resides in preadipocytes per se and potentially results from reduced levels of critical transcription factors essential for adipogenesis. Altogether, our findings demonstrate that silencing Nck1 modulates 3T3-L1 preadipocyte functions and gene signatures.

Silencing Nck1 in 3T3-L1 Preadipocytes Promotes PDGFRα Activation and Signaling {#sec2.5}
-------------------------------------------------------------------------------

Activation of PDGFRα inhibits WAT development by shifting precursor cells toward a stromal fibroblastic lineage secreting collagen rather than a preadipocyte lineage ([@bib17], [@bib26], [@bib35]). In pull-down assays, we found that Nck1 interacts with PDGFRα through its SH2 domain in pervanadate (PV)-treated 3T3-L1 preadipocyte lysate ([Figure S6](#mmc1){ref-type="supplementary-material"}A). We also detected increased PDGFRα phosphorylation on pY^754^ activation site in PV-treated Nck1-deficient 3T3-L1 preadipocytes compared with similarly treated control cells ([Figure S6](#mmc1){ref-type="supplementary-material"}B, short exposure). Increased phosphorylation of PDGFRα on Y^754^ is also seen in the absence of PV treatment in Nck1-deficient 3T3-L1 preadipocytes ([Figure S6](#mmc1){ref-type="supplementary-material"}B, long exposure). Therefore, increased phosphorylation of PDGFRα on Y^754^ suggests enhanced basal activation of PDGFRα in Nck1-deficient 3T3-L1 preadipocytes. Consistently, basal pAKT, p-p70S6 kinase, cyclin D1, and cytosolic FOXO1 were all increased in serum-starved Nck1-deficient 3T3-L1 preadipocytes ([Figure S6](#mmc1){ref-type="supplementary-material"}C), suggesting that Nck1 limits PDGFRα activation and signaling in preadipocytes. Importantly, we found that PDGF-A-induced PDGFRα activation and signaling is also increased in Nck1-deficient 3T3-L1 preadipocytes as shown by increased phosphorylation of PDGFRα on Y^754^, phosphorylation of AKT on both activation sites T^308^ and S^473^, and phosphorylation of ERK1/2 to a lower extent ([Figures 6](#fig6){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}D). Therefore, increased PDGRα activation and signaling could contribute to impair adipocyte differentiation in 3T3-L1 preadipocytes depleted of Nck1. On the other hand, we eliminated that enhanced differentiation in 3T3-L1 preadipocytes stably overexpressing FLAG-Nck1 ([Figure 4](#fig4){ref-type="fig"}B) clearly relies on attenuated PDGFRα activation and signaling, given that PDGF-A-induced PDGFRα pY^754^, pAKT, and pERK are mostly comparable to control 3T3-L1 preadipocytes ([Figure S7](#mmc1){ref-type="supplementary-material"}A). Finally, we excluded that Nck1 loss and gain of function in 3T3-L1 preadipocytes affect adipocyte differentiation by modulating PDGFRα expression level ([Figure S7](#mmc1){ref-type="supplementary-material"}B).Figure 6Nck1 Deficiency Promotes PDGFRα Activation and Signaling in 3T3-L1 Preadipocytes and Enhances Collagen Deposition in WAT(A) Western blots analysis of PDGF-A (5 ng/μL)-induced PDGFRα activation and signaling in control and Nck1-depleted 3T3-L1 preadipocytes (representative of n = 3).(B) Relative expression of collagen genes in control and Nck1-depleted 3T3-L1 preadipocytes (n = 3/group).(C) Picrosirius red and Masson\'s trichrome staining of eWAT and scWAT from *Nck1*^*+/+*^ and *Nck1*^*−/−*^ mice at week 16 post-weaning (n = 3/group). Representative images were taken at 20× magnification.(D) Hydroxyproline content in eWAT from *Nck1*^*+/+*^ and *Nck1*^*−/−*^ mice at week 16 post- weaning (n = 3--5/group).(E and F) (E) Relative expression of PDGF-A and PDGF-C in control and Nck-1-depleted 3T3-L1 preadipocytes (n = 3/group) (F) Relative expression of PDGF-A in scWAT of *Nck1*^*+/+*^ and *Nck1*^*−/−*^ at week 5 post-weaning (n = 3--4).(G) Western blot analysis of indicated proteins in eWAT from *Nck1*^*+/+*^ and *Nck1*^*−/−*^ at week 16 post-weaning (n = 4). Data are mean ± SEM. Statistical significance evaluated by unpaired Student *t test* is reported as \*p≤0.05.

Increased PDGFRα activation in adipocyte precursor cells is known to promote collagen gene expression and deposition of extra-cellular matrix (ECM) leading to adipose tissue fibrosis in adult mice ([@bib17], [@bib26], [@bib35]). In agreement, increased PDGFRα activation and signaling in Nck1-deficient 3T3-L1 preadipocytes correlates with higher expression of various collagen genes, as well as *Tgfb1*, a potent mediator of collagen gene expression in various cell types ([@bib27]) ([Figure 6](#fig6){ref-type="fig"}B). These findings are supported by *in vivo* data showing increased picrosirius red and Masson\'s trichrome staining, revealing enhanced collagen deposition in both eWAT and scWAT in *Nck1*^*−/−*^ mice ([Figure 6](#fig6){ref-type="fig"}C). Increased collagen deposition is further confirmed by increased hydroxyproline content in eWAT of *Nck1*^*−/−*^ mice ([Figure 6](#fig6){ref-type="fig"}D). In addition, the pro-fibrosis cytokines, transforming growth factor β1 and fibronectin, appear elevated in eWAT of *Nck1*^*−/−*^ mice ([Figure S7](#mmc1){ref-type="supplementary-material"}D). Overall, our findings suggest that lack of Nck1 impairs adipogenesis by shifting the preadipocyte phenotype toward a less committed cell fate with reduced preadipocyte lineage markers, enhanced proliferation, and increased collagen production.

To understand how Nck1 deficiency leads to increased PDGFRα activation and signaling, we assessed the expression of various PDGF ligands in 3T3-L1 preadipocytes. In contrast to PDGF-A and PDGF-C mRNAs, 3T3-L1 preadipocytes expressed very low levels of PDGF-B and PDGF-D mRNAs. Nonetheless, in Nck1-deficient 3T3-L1 preadipocytes, we found that the PDGF-A mRNA level is upregulated, whereas PDGF-C mRNA level is not changed ([Figure 6](#fig6){ref-type="fig"}E). Our findings suggest that increased expression of PDGF-A by silencing Nck1 in 3T3-L1 preadipocytes could contribute to further induce PDGFRα activation, leading to enhanced PDGFRα signaling. On the other hand, PDGF-A mRNA is not changed in FLAG-Nck1 3T3-L1 preadipocytes ([Figure S7](#mmc1){ref-type="supplementary-material"}C), consistent with no change in PDGF-A-induced PDGFRα signaling ([Figure S7](#mmc1){ref-type="supplementary-material"}A). Interestingly, in WAT of *Nck1*^−/−^ mice, PDGF-A mRNA and protein levels tend to be higher and positively correlate with increased cyclin D1 expression, whereas the expression of PDGFRα remains unchanged ([Figures 6](#fig6){ref-type="fig"}F and 6G). These results further support that Nck1 deficiency promotes PDGFRα activation and signaling, leading to increased expression of collagen genes in preadipocytes and ECM accumulation in WAT.

PDGFRα Mediates the Effects of Silencing Nck1 in 3T3-L1 Preadipocytes {#sec2.6}
---------------------------------------------------------------------

To determine whether PDGFRα mediates the effects of silencing Nck1 in preadipocytes, we treated Nck1-depleted and control 3T3-L1 preadipocytes with imatinib, a potent PDGFR inhibitor ([@bib13]). In this context, we found that induction of collagen genes in Nck1-depleted 3T3-L1 preadipocytes is prevented by overnight treatment with imatinib ([Figure 7](#fig7){ref-type="fig"}A). Furthermore, we next used specific inhibitors to determine which PDGFRα pathway is involved in inducing collagen genes in Nck1-depleted 3T3-L1 preadipocytes. Treatment of Nck1-depleted preadipocytes with an Akt inhibitor (Akti) completely prevents the induction of *Col6A3, Col3A1,* and *Col1A1.* Interestingly, impeding ERK activation using a MAPK/ERK Kinase (MEK) inhibitor (U0129) has no effect on the induction of *Col6A3* and *Col3A1* in Nck1-depleted 3T3-L1 preadipocytes, whereas it prevents *Col1A1* induction ([Figure 7](#fig7){ref-type="fig"}A), suggesting differential regulation of collagen genes in Nck1-depleted 3T3-L1 preadipocytes.Figure 7PDGFRα Mediates the Effects of Silencing Nck1 on Collagen Genes Expression and Differentiation in 3T3-L1 Preadipocytes(A) Effect of imatinib (1 μM), Akti (10 μM), and U0126 (10 μM) and downregulation of either PDGFRα or PDGF-A on indicated collagen gene expression in siControl and siNck1 3T3-L1 preadipocytes (n = 3--7/condition).(B) Effect of imatinib on differentiation of siControl and siNck1 3T3-L1 preadipocytes (n = 3/group). Differentiation is assessed at day 6 using light microscopy images (10× magnification) showing lipid droplets formation, lipid accumulation by oil red O quantification, and relative *Pparg* expression by qPCR (n = 3). Data are mean ± SEM.Statistical significance evaluated by unpaired Student\'s t test or two-way ANOVA is reported as \*p ≤ 0.05 and \*\*p ≤ 0.01.

Imatinib is reported to be a potent inhibitor of PDGFRα and β, as well as Bcr-Abl, Abl, and c-kit tyrosine kinases. To our knowledge, Bcr-Abl, Abl, and c-kit are not expressed in 3T3-L1 preadipocytes. However, to discriminate between PDGFR isoforms mediating the effects of silencing Nck1 in 3T3-L1 preadipocytes on collagen gene expression, we simultaneously silenced PDGFRα and Nck1 through co-transfection of specific siRNAs. In parallel, we also determined the effects of silencing PDGF-A ligand expression in Nck1-depleted preadipocytes, given we found that deficiency in Nck1 induces PDGF-A mRNA in preadipocytes ([Figure 6](#fig6){ref-type="fig"}E) as well as PDGF-A ligand in WAT ([Figure 6](#fig6){ref-type="fig"}F). As expected, PDGFRα and PDGF-A siRNAs were specific in downregulating their respective mRNA ([Figures S8](#mmc1){ref-type="supplementary-material"}A and S8B). Interestingly, silencing Nck1 in combination with PDGFRα or PDGF-A prevents induction of PDGF-A mRNA compared with Nck1-depleted preadipocytes ([Figure S7](#mmc1){ref-type="supplementary-material"}E). In addition, depletion of PDGFRα or PDGF-A prevents the effects of silencing Nck1 on collagen gene expression in 3T3-L1 preadipocytes ([Figure 7](#fig7){ref-type="fig"}A), demonstrating that the effects of silencing Nck1 in preadipocytes are mediated by PDGFRα.

We next assessed whether neutralizing PDGFRα activity during differentiation would restore adipogenesis in Nck1-deficient 3T3-L1 preadipocytes. For this, we decided to introduce imatinib during differentiation rather than to address this point using Nck1-deficient 3T3-L1 preadipocytes co-transfected with PDGFRα or PDGF-A siRNAs. This is based on the rationale that imatinib completely blocks PDGFRα activation, whereas siRNA PDGFRα only partially decreases PDGFRα activity due to incomplete downregulation of PDGFRα expression. Similarly, downregulating PDGF-A still allows serum-induced PDGFRα activation. Therefore, their effects on restoring adipocyte differentiation of Nck-1-depleted 3T3-L1 preadipocytes could be mitigated. In this perspective, we observed that adding imatinib to the differentiation cocktail improves differentiation of Nck1-depleted 3T3-L1 preadipocytes, as shown by comparable levels of lipid droplet formation (light microscopy) and quantification of oil red O between Nck1-depleted and control 3T3-L1 preadipocytes. Although imatinib has been reported to promote adipocyte differentiation of primary human mesenchymal stromal cells ([@bib13]), it has no significant effect on lipid droplet formation and oil red O content in control 3T3-L1 preadipocytes ([Figure 7](#fig7){ref-type="fig"}B). Recovery of adipocyte differentiation by imatinib in Nck1-deficient 3T3-L1 preadipocytes is further supported by the induction of *Pparg* to the level found in control cells similarly treated with imatinib ([Figure 7](#fig7){ref-type="fig"}B). Altogether, these findings support that enhanced PDGFRα activation and signaling mediate the effects of silencing Nck1 in 3T3-L1 preadipocytes and could contribute to impair adipogenesis *in vivo*.

Discussion {#sec3}
==========

SH domain-containing adaptor proteins of the Nck family, Nck1 and Nck2, play an important role in mediating cell surface receptor signaling that orchestrates crucial cellular responses such as cell adhesion, migration and invasion ([@bib11], [@bib19], [@bib28]), and low-affinity antigen response ([@bib4]). However, the implication of Nck in intracellular signaling pathways governing WAT biology has never previously been investigated. In this perspective, our work addressing the role of both Ncks in WAT unveils insights on mechanisms regulating adipogenesis. Indeed, we have previously demonstrated that Nck2 limits adiposity in mice and adipocyte differentiation *in vitro* ([@bib12], [@bib15]). Mechanistically, we provided evidence that Nck2 regulates adipogenesis by controlling activation of PERK during preadipocyte to adipocyte transition. Herein, we report that Nck1 is required for normal WAT development. Indeed, Nck1 deficiency in mice results in smaller WAT depots and specific deletion of Nck1 abrogates the ability of murine and human preadipocytes to differentiate into adipocytes *in vitro*. Moreover, we identified that Nck1 interacts with PDGFRα and Nck1 deficiency in preadipocytes leads to enhanced PDGFRα activation and signaling. It is well established that increased PDGFRα activity causes adipose tissue fibrosis in mice by inhibiting the formation of adipocytes in favor of promoting collagen-expressing fibroblasts ([@bib17], [@bib26], [@bib35]). Accordingly, Nck1-deficient 3T3-L1 preadipocytes display enhanced PDGFRα activation and signaling, leading to greater collagen expression. Furthermore, WAT depots in *Nck1*^*−/−*^ mice present increased collagen accumulation that correlates with a reduced population of adipocyte precursor cells. Nck1 has been identified in an activated PDGFRβ complex ([@bib7], [@bib31], [@bib32]), whereas its recruitment to PDGFRα has never been reported. Therefore, Nck1 interaction with activated PDGFRα in preadipocytes represents a mechanism by which PDGFRα activation and signaling is controlled to maintain preadipocytes in an adequate committed state indispensable for their transition to adipocytes. In addition, we reported enhanced proliferation of Nck1-deficient 3T3-L1 cells that correlates with increased PDGFRα activation and signaling. In *Nck1*^*−/−*^ mice, the cell population that is sensitive to PDGFRα stimulation might not be the specific adipogenic precursor cells that we analyzed (Lin−;CD29+;CD34+;Sca1+;PDGFRα+), but rather the profibrotic precursors (Lin−;GP38+; PDGFRα+) as reported by others ([@bib26]). Further investigation is required to identify adipocyte precursor population responsive to PDGFRα activation in *Nck1*^*−/−*^ mice that could contribute to alter the fate of adipocyte precursors in *Nck1*^*−/−*^ mice. Nonetheless, altogether our findings suggest that an imbalance between collagen producing fibroblasts and committed preadipocytes rather than differentiation per se is responsible for the reduced adiposity in *Nck1*^*−/−*^ mice. However, the fact that mice lacking Nck1 are not lipodystrophic suggests adipogenic precursor cells\' heterogeneity, with a role for Nck1 only in a subset of adipocyte precursor cells.

In mammals, obesity has been associated with increased ECM deposition and fibrosis that affects progenitor adipogenic capacity leading to WAT dysfunction ([@bib1], [@bib10], [@bib18], [@bib26]). Our findings demonstrate that Nck1 expression is increased during obesogenic WAT expansion in mice and correlates with adipogenic markers in humans. Further investigations are required to demonstrate whether Nck1 plays a protective role in limiting ECM accumulation and fibrosis during WAT expansion associated with obesity. In this instance, WAT expansion and function in *Nck1*^*−/−*^ mice fed an HFD should be explored further.

Several studies have shown that Nck1 and Nck2 are functionally redundant and share common interacting proteins ([@bib5], [@bib20], [@bib22]). In agreement, individual Nck knockout mice are viable with no apparent phenotype, whereas the Nck1 and Nck2 double knockout mice are embryonically lethal ([@bib3]). However, increasing evidence supports specific functions and interacting partners for Nck1 and Nck2 ([@bib29], [@bib30]). In this perspective, our studies on the role of Nck adaptor proteins in WAT development reveal that both Ncks regulate adipogenesis, but in an opposite manner and at different stages during this process. Nck2 is involved in regulating the transition of preadipocyte into adipocyte by regulating PERK activation and signaling ([@bib12], [@bib15]), whereas our findings reveal that Nck1 controls preadipocyte commitment by modulating PDGFRα activation and signaling, and is required to maintain an adequate number of adipocyte precursor cells in WAT. Analysis of Nck1 and Nck2 interactome profiles in the preadipocyte and adipocyte might provide an understanding of how these two highly identical adaptor proteins differentially regulate WAT homeostasis.

Nevertheless, in this study we clearly established in mouse 3T3-L1 and human SGBS preadipocytes that Nck1 regulates adipogenesis in a cell-autonomous manner. Furthermore, we provide strong evidence that Nck1 regulation of adipogenesis involves a tight control of collagen expression through activation of PDGFRα in preadipocytes. Indeed, treatment with imatinib, a PDGFR inhibitor, and Akti, an Akt inhibitor, both prevented increased collagen expression in Nck1-deficient 3T3-L1 preadipocytes. Downregulation of PDGFRα also prevents increased collagen expression in Nck1-depleted preadipocytes, suggesting that PDGFRα mediates the preadipocyte phenotype upon Nck1 depletion. More importantly, imatinib maintained during differentiation restores induction of PPARγ and improves adipogenesis in Nck1-deficient 3T3-L1 cells. Although the exact mechanism by which Nck1 regulates PDGFRα activity in preadipocytes remains to be elucidated, our findings show that increased production of the PDGF-A ligand by silencing Nck1 in 3T3-L1 cells could contribute to higher activation of PDGFRα. Indeed, PDGFRα-mediated induction of collagen genes is prevented upon downregulation of PDGF-A in Nck1-depleted 3T3-L1 preadipocytes, suggesting that enhanced production of PDGF-A contributes to further increase PDGFRα activation and signaling. In addition, Nck1 interaction with the activated PDGFRα could mediate the recruitment of a phosphatase or a kinase involved in attenuating PDGFRα activation and signaling. For instance, we recently demonstrated that Nck1, which interacts with the tyrosine phosphatase PTP1B through its SH3 domains ([@bib9], [@bib23], [@bib38]), regulates PTP1B expression and controls receptor tyrosine kinases-induced activation of the PI3K/AKT pathway ([@bib23]). On the other hand, we have previously shown that Nck1 interacts with the isoform γ2 casein kinase I (CKIγ2) through its SH3 domains ([@bib25]) and that CKIγ2 negatively regulates PDGFRβ activation by increasing its phosphorylation on serine residues ([@bib2]). Therefore, silencing Nck1 in 3T3-L1 preadipocytes could potentially prevent PTP1B or CKIγ2 translocation in close proximity of PDGFRα, thus enhancing its activation and signaling. More investigation is needed to further explore these avenues.

Overall, our study provides insight on the role of Nck1 in regulating adipocyte precursor cells and preadipocytes through modulation of PDGFRα activation. We have identified Nck1 as a regulator of adipose tissue biology in mouse and humans through various *in vitro* and *in vivo* approaches. We believe that Nck1 regulation of WAT development could potentially highlight a powerful avenue to overcome or treat obesity.
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All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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